Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-01

Clinical Trial Update: SLOS: The Effect of Simvastatin in Patients Receiving Cholesterol Supplementation [NA]

View source ↗

Summary

Clinical trial update for SLOS evaluating simvastatin in patients receiving cholesterol supplementation; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Smith-Lemli-Opitz Syndrome | NA | Status: TERMINATED | Results posted: 2019-10-01